Ubs Asset Management Americas Inc Exact Sciences Corp Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,339,897 shares of EXAS stock, worth $77.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,339,897
Previous 1,763,545 24.02%
Holding current value
$77.9 Million
Previous $74.5 Million 22.45%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$42.43 - $70.83 $18 Million - $30 Million
-423,648 Reduced 24.02%
1,339,897 $91.2 Million
Q2 2024

Aug 13, 2024
BUY
$41.33 - $74.26 $18.6 Million - $33.3 Million
449,075 Added 34.16%
1,763,545 $74.5 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $30 Million - $39.4 Million
533,631 Added 68.34%
1,314,470 $90.8 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $3.5 Million - $4.49 Million
59,236 Added 8.21%
780,839 $57.8 Million
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $7.69 Million - $11.6 Million
116,677 Added 19.29%
721,603 $49.2 Million
Q1 2023

May 15, 2023
BUY
$47.19 - $70.77 $1.1 Million - $1.65 Million
23,367 Added 4.02%
604,926 $41 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $58,696 - $102,792
-1,934 Reduced 0.33%
581,559 $28.8 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $1.03 Million - $1.59 Million
-32,190 Reduced 5.23%
583,493 $19 Million
Q2 2022

Aug 12, 2022
SELL
$35.61 - $76.23 $1.05 Million - $2.25 Million
-29,569 Reduced 4.58%
615,683 $24.3 Million
Q1 2022

May 16, 2022
BUY
$57.56 - $82.54 $1.13 Million - $1.62 Million
19,644 Added 3.14%
645,252 $45.1 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $956,420 - $1.33 Million
13,192 Added 2.15%
625,608 $48.7 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $1.11 Million - $1.52 Million
12,266 Added 2.04%
612,416 $58.5 Million
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $4.69 Million - $6.98 Million
50,097 Added 9.11%
600,150 $74.6 Million
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $5.33 Million - $7.08 Million
45,694 Added 9.06%
550,053 $72.5 Million
Q4 2020

Mar 01, 2021
BUY
$99.61 - $142.12 $4.19 Million - $5.98 Million
42,088 Added 9.1%
504,359 $66.8 Million
Q3 2020

Nov 13, 2020
SELL
$72.92 - $102.01 $514,013 - $719,068
-7,049 Reduced 1.5%
462,271 $47.1 Million
Q2 2020

Aug 14, 2020
SELL
$55.75 - $92.75 $6.03 Million - $10 Million
-108,099 Reduced 18.72%
469,320 $40.8 Million
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $992,108 - $2.73 Million
-26,177 Reduced 4.34%
577,419 $33.5 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $5.38 Million - $6.91 Million
69,268 Added 12.96%
603,596 $55.8 Million
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $3.54 Million - $4.8 Million
39,149 Added 7.91%
534,328 $48.3 Million
Q2 2019

Aug 15, 2019
BUY
$89.51 - $118.04 $4.56 Million - $6.02 Million
50,987 Added 11.48%
495,179 $0
Q1 2019

May 14, 2019
BUY
$61.98 - $96.5 $749,524 - $1.17 Million
12,093 Added 2.8%
444,192 $0
Q4 2018

Feb 13, 2019
SELL
$56.04 - $82.66 $12.7 Million - $18.8 Million
-227,245 Reduced 34.47%
432,099 $27.3 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $3.88 Million - $6.47 Million
-80,249 Reduced 10.85%
659,344 $0
Q2 2018

Aug 14, 2018
SELL
$37.84 - $69.96 $3.39 Million - $6.27 Million
-89,650 Reduced 10.81%
739,593 $0
Q1 2018

May 14, 2018
SELL
$39.82 - $57.53 $1.76 Million - $2.55 Million
-44,323 Reduced 5.07%
829,243 $0
Q4 2017

Feb 09, 2018
SELL
$46.49 - $60.51 $9.25 Million - $12 Million
-199,003 Reduced 18.55%
873,566 $0
Q3 2017

Nov 13, 2017
BUY
$37.05 - $47.12 $39.7 Million - $50.5 Million
1,072,569
1,072,569 $0

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email